X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (86) 86
male (73) 73
index medicus (66) 66
prostate cancer (46) 46
oncology (43) 43
article (42) 42
prostatic neoplasms - radiotherapy (36) 36
aged (34) 34
radiotherapy (34) 34
cancer (29) 29
radiology, nuclear medicine & medical imaging (29) 29
middle aged (28) 28
pediatrics (26) 26
prostate (25) 25
hematology, oncology and palliative medicine (23) 23
infant, newborn (22) 22
radiology (22) 22
abridged index medicus (21) 21
female (20) 20
prospective studies (20) 20
care and treatment (19) 19
follow-up studies (19) 19
prostatic neoplasms - pathology (19) 19
risk factors (19) 19
patients (17) 17
radical prostatectomy (17) 17
health aspects (16) 16
infants (16) 16
radiology and nuclear medicine (16) 16
radiation (15) 15
radiotherapy dosage (15) 15
risk (15) 15
aged, 80 and over (14) 14
analysis (14) 14
brachytherapy (14) 14
gestational age (14) 14
cerebral-palsy (13) 13
prostatic neoplasms - mortality (13) 13
radiation-therapy (13) 13
retrospective studies (13) 13
carcinoma (12) 12
infant, extremely premature (12) 12
men (12) 12
neoplasms (12) 12
nuclear radiation (12) 12
child (11) 11
children (11) 11
low-birth-weight (11) 11
outcomes (11) 11
prostatic neoplasms - therapy (11) 11
quality of life (11) 11
research (11) 11
toxicity (11) 11
urology & nephrology (11) 11
adult (10) 10
age (10) 10
child, preschool (10) 10
prognosis (10) 10
time factors (10) 10
cohort studies (9) 9
infant, premature (9) 9
prostatic neoplasms - drug therapy (9) 9
survival (9) 9
treatment outcome (9) 9
adenocarcinoma - radiotherapy (8) 8
brain (8) 8
clinical neurology (8) 8
conformal radiotherapy (8) 8
inflammation (8) 8
inflammation-related proteins (8) 8
neoplasm staging (8) 8
prostate-specific antigen - blood (8) 8
prostatectomy (8) 8
radiation doses (8) 8
radiation therapy (8) 8
radioisotope brachytherapy (8) 8
rectum (8) 8
algorithms (7) 7
clinical trials (7) 7
diagnosis (7) 7
infant (7) 7
irradiation (7) 7
logistic models (7) 7
patient outcomes (7) 7
public health (7) 7
randomized-trial (7) 7
rectum - radiation effects (7) 7
survival rate (7) 7
adenocarcinoma (6) 6
androgen antagonists - therapeutic use (6) 6
autism (6) 6
blood (6) 6
brain-damage (6) 6
cerebral palsy (6) 6
child development (6) 6
developmental disabilities - etiology (6) 6
disease-free survival (6) 6
epidemiology (6) 6
multivariate analysis (6) 6
neoplasm grading (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 2, pp. 294 - 302
Purpose Long-term (LT) androgen suppression (AS) with radiation therapy (RT) is a standard treatment of high-risk, localized prostate cancer (PCa). Radiation... 
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | DEPRIVATION | ORAL ETOPOSIDE | GROUP PROTOCOL 92-02 | RADIOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | III TRIAL | DURATION | ESTRAMUSTINE | PACLITAXEL | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Hormonal - adverse effects | Early Termination of Clinical Trials | Neoplasm Grading | Time Factors | Chemotherapy, Adjuvant - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Adult | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Etoposide - therapeutic use | Paclitaxel - therapeutic use | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Androgen Antagonists - therapeutic use | Aged | Combined Modality Therapy - methods | Estramustine - therapeutic use | Clinical trials | Radiotherapy | Health aspects | Adjuvant treatment | Radiation | Cancer | Index Medicus | PROSTATE | LUTEINIZING HORMONE | PATIENTS | NEOPLASMS | CLINICAL TRIALS | FAILURES | METASTASES | ANTIGENS | TOXICITY | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | LIBERINS | INHIBITION | DATA | HYPOTHESIS | RADIOLOGY AND NUCLEAR MEDICINE | ANDROGENS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 88, Issue 5, pp. 1074 - 1084
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 3, pp. 693 - 699
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 4, pp. 770 - 777
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 3, pp. 579 - 586
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 946 - 953
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 86, Issue 3, pp. 546 - 553
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. e39 - e46
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 86, Issue 5, pp. 835 - 841
Journal Article
American Journal of Men's Health, ISSN 1557-9883, 1/2017, Volume 11, Issue 1, pp. 73 - 81
The optimum use of androgen deprivation therapy (ADT) in high-risk prostate cancer patients has not been defined in the setting of dose-escalated external beam... 
hormone replacement therapy | prostate cancer | outcomes research | oncology/cancer | physiological and endocrine disorders | research | SURVIVAL | ADENOCARCINOMA | RANDOMIZED CONTROLLED-TRIAL | SUPPRESSION | IRRADIATION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | MEN | RADIOTHERAPY | CARCINOMA | HORMONAL-THERAPY | SHORT-TERM | cancer | oncology
Journal Article
Advances in Radiation Oncology, ISSN 2452-1094, 2017, Volume 2, Issue 3, pp. 249 - 258
Abstract Purpose Moderately hypofractionated intensity modulated radiation therapy (HIMRT) for prostate cancer shortens the treatment course while providing... 
Hematology, Oncology, and Palliative Medicine
Journal Article
Journal Article